On May 5, 2025, MAIA Biotechnology, Inc. announced a private placement of 633,333 shares at $1.50 each, raising approximately $950,000, with total expected gross proceeds of about $1.08 million for funding trials and working capital. This includes participation from company directors, with shares and warrants for their investment noted.